You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 4, April 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (173)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nonpituitary Neoplasms and Cushing's Syndrome

Ectopic "Adrenocorticotropin" Produced by Nonpituitary Neoplasms as a Cause of Cushing's Syndrome

GRANT W. LIDDLE, M.D.; DONALD P. ISLAND, B.S.; ROBERT L. NEY, M.D.; WENDELL E. NICHOLSON, B.S.; NAOKATA SHIMIZU, M.D.

Arch Intern Med. 1963;111(4):471-475.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

A recent paper1 published jointly from this laboratory and that of Dr. John A. Luetscher developed the concept that certain tumors of "nonendocrine" tissues can give rise to Cushing's syndrome through the mechanism of secreting an adrenocorticotropic substance which promotes growth of the adrenal cortices and stimulates the secretion of adrenal steroids. It was demonstrated that patients harboring such tumors had excessive concentrations of adrenocorticotropic material in their plasma and that they secreted excessive quantities of cortisol (hydrocortisone), resulting in high levels of plasma and urinary 17-hydroxycorticosteroids (17-OHCS). The hypersecretion of cortisol could not be suppressed by the administration of exogenous steroids such as dexamethasone. Clinical manifestations varied from patient to patient depending upon such factors as the severity of the endocrinologic disturbance, the duration of the disorder, and the sex of the patient.

A sine qua non in the diagnosis of this clinicopathological entity is the demonstration . . . [Full Text PDF of this Article]


Author Affiliations

NASHVILLE, TENN.

Department of Medicine, Vanderbilt University School of Medicine.


Footnotes

Received for publication Dec. 26, 1962; accepted Dec. 28.

Presented before the American Clinical and Climatological Association, Oct. 26, 1962.

These studies were supported by grants-in-aid from the U.S. Public Health Service (AM-05318, 2A-5092, and OG-2).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.